The University of Warwick Library - WebBridge
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial
Earl,
Helena M..
The Lancet Oncology.
v.
16.
no.
6.
2015-06.
p.
656 -
666...
issn:
1470-2045
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.